These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3491039)

  • 1. Effect of lymphokines on natural killer cytotoxicity in patients with high risk of developing the acquired immune deficiency syndrome.
    de la Barrera S; Olabuenaga S; Felippo M; de Elizalde de Bracco MM
    Immunol Lett; 1986 Nov; 13(6):307-11. PubMed ID: 3491039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
    Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
    Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome.
    Reddy MM; Chinoy P; Grieco MH
    J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
    Rook AH; Masur H; Lane HC; Frederick W; Kasahara T; Macher AM; Djeu JY; Manischewitz JF; Jackson L; Fauci AS; Quinnan GV
    J Clin Invest; 1983 Jul; 72(1):398-403. PubMed ID: 6308051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K; Tilden AB; Balch CM
    J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans.
    Yasukawa M; Nakagomi O; Kobayashi Y
    Clin Exp Immunol; 1990 Apr; 80(1):49-55. PubMed ID: 2157566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells.
    Hofmann B; Odum N; Jakobsen BK; Platz P; Ryder LP; Nielsen JO; Gerstoft J; Svejgaard A
    Scand J Immunol; 1986 Jun; 23(6):669-78. PubMed ID: 2940675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human cytotoxic lymphocytes directed against cells infected with typhus group rickettsiae: evidence for lymphokine activation of effectors.
    Carl M; Dasch GA
    J Immunol; 1986 Apr; 136(7):2654-61. PubMed ID: 3081648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated cytotoxicity in peripheral blood mononuclear cells of severely immunocompromised HIV-infected patients.
    Forthal DN; Landucci G; Robinson WE
    Scand J Immunol; 1997 Jan; 45(1):91-5. PubMed ID: 9010505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood mononuclear cells from AIDS patients release but do not respond to antigen-stimulated NK-activating lymphokines.
    Lapham CK; Sacks LV; Tomar RH
    J Clin Lab Anal; 1989; 3(1):8-13. PubMed ID: 2523964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 enhances natural killing of normal lymphocytes.
    Miyasaka N; Darnell B; Baron S; Talal N
    Cell Immunol; 1984 Mar; 84(1):154-62. PubMed ID: 6607776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cytotoxic activity in intestinal lamina propria and peripheral blood in AIDS and Crohn disease].
    Fink CO; Raedler A; Voss A
    Z Gastroenterol; 1996 Feb; 34(2):111-5. PubMed ID: 8659185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural and functional effects of lipopolysaccharide and interleukin-2 on human NK cells.
    Kang YH; Carl M; Watson LP
    Scanning Microsc; 1988 Sep; 2(3):1567-86. PubMed ID: 3059478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.